期刊文献+

脓毒症患者凝血功能的改变及其意义 被引量:3

Changes and Significance of Coagulation Dysfunction of Sepsis Patients
下载PDF
导出
摘要 目的研究脓毒症患者凝血功能的变化及其意义。方法按照脓毒症诊断标准,将76例患者分为生存组50例和死亡组26例,一经确诊即抽血检查凝血四项、D-二聚体浓度、血小板及白细胞计数。结果与生存组比较,死亡组的APTT、PT显著延长,D-二聚体浓度、白细胞计数显著增高,纤维蛋白原浓度、血小板计数显著降低(P〈0.05)。结论脓毒症患者存在凝血系统功能紊乱,其中D-二聚体浓度、血小板计数与脓毒症的严重程度有显著相关性,对判断患者的预后及评估病情、严重程度有重要意义。 Objective To study the changes of coagulopathy in sepsis patients,and to look for it's clinical significance.Method A total of 76 patients were enrolled in present study.According to the diagnostic criteria for sepsis,these patients were divided into two groups,survival(n=50)and death(n=20).The venous blood samples were taken from the patients as soon as they entered ICU and following parameters were determined:prothrombin time (PT),activated partial thromboplastin time (APTT),fibrinogen (Fib),intemational normalized ratio (INR),D-dimer, platelet (PLT),and white blood cells (WBC).Results APTT and PT were longer in death group.D-dimer and WBC were higher in death group.Fib and PLT were lower in death group.All the differences were of statistical significance (P〈0.05).These changes were closely correlated with the APACHE Ⅱ score.Conclusions The coagulation dysfunction is much severe in the traumatic patients with sepsis.The severity of post traumatic sepsis is significantly related only with PLT and D-dimer,which may therefore act as adoptable parameters in the developing system of sepsis score.
出处 《中国血液流变学杂志》 CAS 2009年第1期58-59,77,共3页 Chinese Journal of Hemorheology
关键词 脓毒症 凝血紊乱 sepsis coagulation dysfunction
  • 相关文献

参考文献8

  • 1Balk RA.Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock[J]. Crit Care Clin,2000,16:337-352.
  • 2Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ AC-CP/ATS/SIS international sepsis definition conference[J]. Intensive Care Med,2003,29(4):530.
  • 3盛志勇,姚咏明,林洪远.全身炎症反应和多器官功能障碍综合征认识的变迁及现状[J].解放军医学杂志,2002,27(2):98-100. 被引量:18
  • 4Knaus WA, Draper EA, Wagner DP,et aI.APACHE Ⅱ :A severity of disease classification system[J].Crit Care Med, 1985, 13(10):818-829.
  • 5苏艳丽,王红,张淑文.脓毒症的凝血功能紊乱与抗凝治疗研究进展[J].中国危重病急救医学,2006,18(11):698-701. 被引量:45
  • 6Taylor EB Jr.Response of anticoagulant pathways in disseminated intravascular coagulation[J].Semin Thromb Hemost, 2001,27:619.
  • 7Vervloet NG,Thijs LG,Hack CE.Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock[J].SeminThrob Hemost, 1998,24:33.
  • 8Bakhshi S,Arya LS.Diagnosis and treatment of disseminated intravascular c0agulation[J].Indian Pediatr,2003,40(8):721.

二级参考文献55

  • 1王红,张淑文,赵立业,王宝恩,魏东,刘飒,张叔伦.中药912液防治大鼠内毒素所致急性DIC的实验研究[J].中国中西医结合杂志,2004,24(S1):265-268. 被引量:5
  • 2王文江,姚咏明.中医药抗内毒素血症治疗的研究进展[J].中国中西医结合急救杂志,2004,11(5):317-320. 被引量:38
  • 3邓烈华,姚华国,邵义明.血必净对脓毒血症患者前降钙素影响的临床观察[J].实用医技杂志,2005,12(06B):1590-1591. 被引量:14
  • 4艾宇航,张丽娜,龚华,徐道妙,赵双平,陈江辉.低分子肝素治疗脓毒症的前瞻性临床研究[J].中国危重病急救医学,2005,17(12):736-739. 被引量:43
  • 5Thijs L G,de Boer J P,de Groot M C,et al.Coagulation disorders in septic shock[J].Intensive Care Med,1993,19 (Suppl 1):S8-15.
  • 6Szaba F M,Smiley S T.Roles for thrombin and fibrin(ogen) in cytokine/chemo-kine production and macrophage adhesion in vivo[J].Blood,2002,99:1053-1059.
  • 7Minnema M C,Chang A C,Jansen P M,et al.Recombinant human antithrombin Ⅲ improves survival and attenuates inflammatory responses in baboons lethally challenged with escherichia coli[J].Blood,2000,95:1117-1123.
  • 8Nawroth P P,Stern D M.Modulation of endothelial cell hemostatic properties by tumor necrosis factor[J].J Exp Med,1986,163:740-745.
  • 9Hoek J A,Sturk A,ten Cate J W,et al.Laboratory and clinical evaluation of an assay of thrombin-antithrombinⅢ complexes in plasma[J].Clin Chem,1988,34:2058-2062.
  • 10Levi M,Roem D,Kamp A M,et al.Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo[J].Thromb Haemost,1993,69:141-146.

共引文献61

同被引文献29

  • 1刘清泉.对脓毒症中医病机特点及治法的认识[J].北京中医,2007,26(4):198-200. 被引量:203
  • 2无.脓毒症的定义、诊断标准、中医证候诊断要点及说明(草案)[J].中华急诊医学杂志,2007,16(8):797-798. 被引量:266
  • 3Massimo Antonelli,Marc Bonten,Maurizio Cecconi,et al.Year in review in Intensive Care Medicine 2012.II:Pneumonia and infection,sepsis,coagulation,hemodynamics,cardiovascularand microcirculation,critical care org-anization,imaging,ethics and legal issues[J].Intensive Care,2013,39(6):345-364.
  • 4Michael Adamzik,Klaus G?rlinger,Jürgen Peters,et al.Whole blood impedance agg-regometry as a biomarker for the diagnosis and prognosis of severe sepsis[J].Critical Care Med,2012,16(2):204-216.
  • 5R.P.Dellinger,Mitchell M.Levy,Andrew Rhodes,et al.Surviving Sepsis Campaign:International Guidelines for Management of Sever e Sepsis and Septic Shock:2012[J].Intensive Care Med,2013,39:165-228.
  • 6Vandijc DM,De Waele JD,Blot SM,et al.Thrombocytopenia and outcome in critically ill patients with bloodstream infection[J].Heart Lung,2010,38(10):31-36.
  • 7Barnard DR,Laterre PF,Vincent JL,et al.Ef ficacy and safety of recombinant human activated protein C for severe sepsis[J].N Engl J Med,2001,328(11):529-541.
  • 8Fisher DJ,Van SE.Protein C levels as a prognostic indicator of outcome in sepsis and related diseases[J].Crit Care Med,2000,32(7):38-47.
  • 9郭海雷,赵遵江,方林森,胡德林,余又新,王春华.参麦注射液对脓毒症保护作用的实验研究[J].现代中西医结合杂志,2008,17(35):5431-5433. 被引量:17
  • 10车妙琳,严玉澄,张芸,顾勇,汪年松,陈楠,毛佩菊,张金元,丁小强,袁伟杰,梅长林,姚建,樊雨良,周毅,张薇,朱汉威,刘梅,金惠敏,钱家麒.上海市药物性急性肾衰竭临床现况分析[J].中华医学杂志,2009,89(11):744-749. 被引量:39

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部